HIV-1 trans-activator of transcription substitutes for oxidative signaling in activation-induced T cell death

Journal of Immunology

Volumn 174, Issue 9, 2005, Pages 5249-5260

  Gülow, Karsten ^a   Kamiński, Marcin ^a   Darvas, Katalin ^a   Süss, Dorothee ^a   Li Weber, Min ^a   Krammer, Peter H ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; FAS ANTIGEN; HYDROGEN PEROXIDE; TRANSACTIVATOR PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; APOPTOSIS; ARTICLE; CALCIUM TRANSPORT; CELL DEATH; CONTROLLED STUDY; CYTOSOL; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; PRIORITY JOURNAL; PROTEIN EXPRESSION; SECOND MESSENGER; SIGNAL TRANSDUCTION; T CELL DEPLETION; T LYMPHOCYTE;

EID: 17844379481     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.174.9.5249     Document Type: Article

References (83)

1. Cohen, J. J. 1993. Apoptosis: the physiologic pathway of cell death. Hosp. Pract. 28:35.
2. Oehm, A., I. Behrmann, W. Falk, M. Pawlita, G. Maier, C. Klas, M. Li-Weber, S. Richards, J. Dhein, B. C. Trauth, et al. 1992. Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/ nerve growth factor receptor superfamily. Sequence identity with the Fas antigen. J. Biol. Chem. 267:10709.
3. Watanabe-Fukunaga, R., C. I. Brannan, N. Itoh, S. Yonehara, N. G. Copeland, N. A. Jenkins, and S. Nagata. 1992. The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J. Immunol. 148:1274.
4. Suda, T., T. Takahashi, P. Golstein, and S. Nagata. 1993. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75:1169.
5. Krammer, P. H. 2000. CD95's deadly mission in the immune system. Nature 407:789.
6. Hiromatsu, K., Y. Aoki, M. Makino, Y. Matsumoto, T. Mizuochi, Y. Gotoh, K. Nomoto, J. Ogasawara, S. Nagata, and Y. Yoshikai. 1994. Increased Fas antigen expression in murine retrovirus-induced immunodeficiency syndrome, MAIDS. Eur. J. Immunol. 24:2446.
7. Brunner, T., R. J. Mogil, D. LaFace, N. J. Yoo, A. Mahboubi, F. Echeverri, S. J. Martin, W. R. Force, D. H. Lynch, C. F. Ware, et al. 1995. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 373:441.
8. Dhein, J., H. Walczak, C. Baumler, K. M. Debatin, and P. H. Krammer. 1995. Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature 373:438.
9. Ju, S. T., D. J. Panka, H. Cui, R. Ettinger, M. el-Khatib, D. H. Sherr, B. Z. Stanger, and A. Marshak-Rothstein. 1995. Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 373:444.
10. Drappa, J., A. K. Vaishnaw, K. E. Sullivan, J. L. Chu, and K. B. Elkon. 1996. Fas gene mutations in the Canale-Smith syndrome, an inherited lymphoproliferative disorder associated with autoimmunity. N. Engl. J. Med. 335:1643.
11. Fisher, G. H., F. J. Rosenberg, S. E. Straus, J. K. Dale, L. A. Middleton, A. Y. Lin, W. Strober, M. J. Lenardo, and J. M. Puck. 1995. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81:935.
12. Ramsdell, F., M. S. Seaman, R. E. Miller, T. W. Tough, M. R. Alderson, and D. H. Lynch. 1994. gld/gld mice are unable to express a functional ligand for Fas. Eur. J. Immunol. 24:928.
13. Rieux-Laucat, F., F. Le Deist, C. Hivroz, I. A. Roberts, K. M. Debatin, A. Fischer, and J. P. de Villartay. 1995. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 268:1347.
14. Baumler, C. B., T. Bohler, I. Herr, A. Benner, P. H. Krammer, and K. M. Debatin. 1996. Activation of the CD95 (APO-1/Fas) system in T cells from human immunodeficiency virus type-1-infected children. Blood 88:1741.
15. Debatin, K. M., A. Fahrig-Faissner, S. Enenkel-Stoodt, W. Kreuz, A. Benner, and P.M. Krammer. 1994. High expression of APO-1 (CD95) on T lymphocytes from human immunodeficiency virus-1-infected children. Blood 83:3101.
16. Eischen, C. M., B. L. Williams, W. Zhang, L. E. Samelson, D. H. Lynch, R. T. Abraham, and P. J. Leibson. 1997. ZAP-70 tyrosine kinase is required for the up-regulation of Fas ligand in activation-induced T cell apoptosis. J. Immunol. 159:1135.
17. Gonzalez-Garcia, A., L. R-Borlado, E. Leonardo, I. Merida, C. Martinez-A, and A. C. Carrera. 1997. Lck is necessary and sufficient for Fas-ligand expression and apoptotic cell death in mature cycling T cells. J. Immunol. 158:4104.
18. Lewis, R. S. 2001. Calcium signaling mechanisms in T lymphocytes. Annu. Rev. Immunol. 19:497.
19. Williamson, J. R. 1986. Role of inositol lipid breakdown in the generation of intracellular signals. II. State of the art lecture. Hypertension 8:140.
20. Li-Weber, M., O. Laur, and P. H. Krammer. 1999. Novel Egr/NF-AT composite sites mediate activation of the CD95 (APO-1/Fas) ligand promoter in response to T cell stimulation. Eur. J. Immunol. 29:3017.
21. Villalba, M., S. Kasibhatla, L. Genestier, A. Mahboubi, D. R. Green, and A. Altman. 1999. Protein kinase C θ cooperates with calcineurin to induce Fas ligand expression during activation-induced T cell death. J. Immunol. 163:5813.
22. Villunger, A., N. Ghaffari-Tabrizi, I. Tinhofer, N. Krumbock, B. Bauer, T. Schneider, S. Kasibhatla, R. Greil, G. Baier-Bitterlich, F. Uberall, D. R. Green, and G. Baier. 1999. Synergistic action of protein kinase C θ and calcineurin is sufficient for Fas ligand expression and induction of a crmA-sensitive apoptosis pathway in Jurkat T cells. Eur. J. Immunol. 29:3549.
23. Sun, Z., C. W. Arendt, W. Ellmeier, E. M. Schaeffer, M. J. Sunshine, L. Gandhi, J. Annes, D. Petrzilka, A. Kupfer, P. L. Schwartzberg, and D. R. Littman. 2000. PKC-θ is required for TCR-induced NF-κB activation in mature but not immature T lymphocytes. Nature 404:402.
24. Cui, H., K. Matsui, S. Omura, S. L. Schauer, R. A. Matulka, G. E. Sonenshein, and S. T. Ju. 1997. Proteasome regulation of activation-induced T cell death. Proc. Natl. Acad. Sci. USA 94:7515.
25. Ivanov, V. N., R. K. Lee, E. R. Podack, and T. R. Malek. 1997. Regulation of Fas-dependent activation-induced T cell apoptosis by cAMP signaling: a potential role for transcription factor NF-κB. Oncogene 14:2455.
26. Matsui, K., S. Omura, H. Cui, S. L. Schauer, G. E. Sonenshein, and S. T. Ju. 1997. Proteasome regulation of Fas ligand cytotoxicity. Eur. J. Immunol. 27:2269.
27. Torgler, R., S. Jakob, E. Ontsouka, U. Nachbur, C. Mueller, D. R. Green, and T. Brunner. 2004. Regulation of activation-induced Fas (CD95/Apo-1) ligand expression in T cells by the cyclin B1/Cdk1 complex. J. Biol. Chem. 279:37334.
28. Latinis, K. M., L. L. Carr, E. J. Peterson, L. A. Norian, S. L. Eliason, and G. A. Koretzky. 1997. Regulation of CD95 (Fas) ligand expression by TCR-mediated signaling events. J. Immunol. 158:4602.
29. Hsu, S. C., M. A. Gavrilin, H. H. Lee, C. C. Wu, S. H. Han, and M. Z. Lai. 1999. NF-κB-dependent Fas ligand expression. Eur. J. Immunol. 29:2948.
30. Arendt, C. W., B. Albrecht, T. J. Soos, and D. R. Littman. 2002. Protein kinase C-θ: signaling from the center of the T-cell synapse. Curr. Opin. Immunol. 14:323.
31. Eichhorst, S. T., M. Muller, M. Li-Weber, H. Schulze-Bergkamen, P. Angel, and P. H. Krammer. 2000. A novel AP-1 element in the CD95 ligand promoter is required for induction of apoptosis in hepatocellular carcinoma cells upon treatment with anticancer drugs. Mol. Cell. Biol. 20:7826.
32. Baumann, S., J. Hess, S. T. Eichhorst, A. Krueger, P. Angel, P. H. Krammer, and S. Kirchhoff. 2003. An unexpected role for FosB in activation-induced cell death of T cells. Oncogene 22:1333.
33. Sandstrom, P. A., and T. M. Buttke. 1993. Autocrine production of extracellular catalase prevents apoptosis of the human CEM T-cell line in serum-free medium. Proc. Natl. Acad. Sci. USA 90:4708.
34. Sandstrom, P. A., M. D. Mannie, and T. M. Buttke. 1994. Inhibition of activation-induced death in T cell hybridomas by thiol antioxidants: oxidative stress as a mediator of apoptosis. J. Leukocyte Biol. 55:221.
35. Devadas, S., L. Zaritskaya, S. G. Rhee, L. Oberley, and M. S. Williams. 2002. Discrete generation of superoxide and hydrogen peroxide by T cell receptor stimulation: selective regulation of mitogen-activated protein kinase activation and fas ligand expression. J. Exp. Med. 195:59.
36. Li-Weber, M., O. Laur, K. Dern, and P. H. Krammer. 2000. T cell activation-induced and HIV Tat-enhanced CD95(APO-1/Fas) ligand transcription involves NF-κB. Eur. J. Immunol. 30:661.
37. Li-Weber, M., and P. H. Krammer. 2003. Function and regulation of the CD95 (APO-1/Fas) ligand in the immune system. Semin. Immunol. 15:145.
38. Finkel, T. H., G. Tudor-Williams, N. K. Banda, M. F. Cotton, T. Curiel, C. Monks, T. W. Baba, R. M. Ruprecht, and A. Kupfer. 1995. Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes. Nat. Med. 1:129.
39. Gougeon, M. L., and L. Montagnier. 1999. Programmed cell death as a mechanism of CD4 and CD8 T cell deletion in AIDS: molecular control and effect of highly active anti-retroviral therapy. Ann. NY Acad. Sci. 887:199.
40. Badley, A. D., A. A. Pilon, A. Landay, and D. H. Lynch. 2000. Mechanisms of HIV-associated lymphocyte apoptosis. Blood 96:2951.
41. Treitinger, A., C. Spada, J. C. Verdi, A. F. Miranda, O. V. Oliveira, M. V. Silveira, P. Moriel, and D. S. Abdalla. 2000. Decreased antioxidant defence in individuals infected by the human immunodeficiency virus. Eur. J. Clin. Invest. 30:454.
42. Favier, A., C. Sappey, P. Leclerc, P. Faure, and M. Micoud. 1994. Antioxidant status and lipid peroxidation in patients infected with HIV. Chem. Biol. Interact. 91:165.
43. Mann, D. A., and A. D. Frankel. 1991. Endocytosis and targeting of exogenous HIV-1 Tat protein. EMBO J. 10:1733.
44. Westendorp, M. O., R. Frank, C. Ochsenbauer, K. Stricker, J. Dhein, H. Walczak, K. M. Debatin, and P. H. Krammer. 1995. Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature 375:497.
45. Chang, H. C., F. Samaniego, B. C. Nair, L. Buonaguro, and B. Ensoli. 1997. HIV-1 Tat protein exits from cells via a leaderless secretory pathway and binds to extracellular matrix-associated heparan sulfate proteoglycans through its basic region. AIDS 11:1421.
46. Ehret, A., M. O. Westendorp, I. Herr, K. M. Debatin, J. L. Heeney, R. Frank, and P. H. Krammer. 1996. Resistance of chimpanzee T cells to human immunodeficiency virus type 1 Tat-enhanced oxidative stress and apoptosis. J. Virol. 70:6502.
47. Li, C. J., D. J. Friedman, C. Wang, V. Metelev, and A. B. Pardee. 1995. Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein. Science 268:429.
48. Yang, Y., B. Dong, P. R. Mittelstadt, H. Xiao, and J. D. Ashwell. 2002. HIV Tat binds Egr proteins and enhances Egr-dependent transactivation of the Fas ligand promoter. J. Biol. Chem. 277:19482.
49. Westendorp, M. O., V. A. Shatrov, K. Schulze-Osthoff, R. Frank, M. Kraft, M. Los, P. H. Krammer, W. Droge, and V. Lehmann. 1995. HIV-1 Tat potentiates TNF-induced NF-κB activation and cytotoxicity by altering the cellular redox state. EMBO J. 14:546.
50. Goudsmit, J., L. Smit, W. J. Krone, M. Bakker, J. van der Noordaa, C. J. Gibbs, L. G. Epstein, and D. C. Gajdusek. 1987. IgG response to human immunodeficiency virus in experimentally infected chimpanzees mimics the IgG response in humans. J. Infect. Dis. 155:327.
51. Heeney, J., R. Jonker, W. Koornstra, R. Dubbes, H. Niphuis, A. M. Di Rienzo, M. L. Gougeon, and L. Montagnier. 1993. The resistance of HIV-infected chimpanzees to progression to AIDS correlates with absence of HIV-related T-cell dysfunction. J. Med. Primatol. 22:194.
52. Armstrong, R. C., T. Aja, J. Xiang, S. Gaur, J. F. Krebs, K. Hoang, X. Bai, S. J. Korsmeyer, D. S. Karanewsky, L. C. Fritz, and K. J. Tomaselli. 1996. Fas-induced activation of the cell death-related protease CPP32 is inhibited by Bcl-2 and by ICE family protease inhibitors. J. Biol. Chem. 271:16850.
53. Peter, M. E., J. Dhein, A. Ehret, S. Hellbardt, H. Walczak, G. Moldenhauer, and P. H. Krammer. 1995. APO-1 (CD95)-dependent and -independent antigen receptor-induced apoptosis in human T and B cell lines. Int. Immunol. 7:1873.
54. Aguilar-Cordova, E., J. Chinen, L. Donehower, D. E. Lewis, and J. W. Belmont. 1994. A sensitive reporter cell line for HIV-1 Tat activity, HIV-1 inhibitors, and T cell activation effects. AIDS Res. Hum. Retroviruses 10:295.
55. Klas, C., K. M. Debatin, R. R. Jonker, and P. H. Krammer. 1993. Activation interferes with the APO-1 pathway in mature human T cells. Int. Immunol. 5:625.
56. Sprick, M. R., M. A. Weigand, E. Rieser, C. T. Rauch, P. Juo, J. Blenis, P. H. Krammer, and H. Walczak. 2000. FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2. Immunity 12:599.
57. Li-Weber, M., O. Laur, A. Hekele, J. Coy, H. Walczak, and P. H. Krammer. 1998. A regulatory element in the CD95 (APO-1/Fas) ligand promoter is essential for responsiveness to TCR-mediated activation. Eur. J. Immunol. 28:2373.
58. Kirsch, T., M. Boehm, O. Schuckert, A. U. Metzger, D. Willbold, R. W. Frank, and P. Rosch. 1996. Cloning, high-yield expression in Escherichia coli, and purification of biologically active HIV-1 Tat protein. Protein Expression Purif. 8:75.
59. Li-Weber, M., M. Giaisi, and P. H. Krammer. 2001. Roles of CCAAT/enhancer-binding protein in transcriptional regulation of the human IL-5 gene. Eur. J. Immunol. 31:3694.
60. Rothe, G., and G. Valet. 1990. Flow cytometric analysis of respiratory burst activity in phagocytes with hydroethidine and 2′,7′- dichlorofluorescin. J. Leukocyte Biol. 47:440.
61. Wang, G. Q., B. R. Gastman, E. Wieckowski, L. A. Goldstein, A. Gambotto, T. H. Kim, B. Fang, A. Rabinovitz, X. M. Yin, and H. Rahinowich. 2001. A role for mitochondrial Bak in apoptotic response to anticancer drags. J. Biol. Chem. 276:34307.
62. 2-M arrest in SW620 human colonie carcinoma cells: initiation of the apoptotic cascade is associated with elevation of the mitochondrial membrane potential (deltapsim). Cancer Res. 60:6704.
63. Ricci, J. E., C. Munoz-Pinedo, P. Fitzgerald, B. Bailly-Maitre, G. A. Perkins, N. Yadava, I. E. Scheffler, M. H. Ellisman, and D. R. Green. 2004. Disruption of mitochondrial function during apoptosis is mediated by caspase cleavage of the p75 subunit of complex 1 of the electron transport chain. Cell 117:773.
64. Bauer, M. K., M. Vogt, M. Los, J. Siegel, S. Wesselborg, and K. Schulze-Osthoff. 1998. Role of reactive oxygen intermediates in activation-induced CD95 (APO-1/Fas) ligand expression. J. Biol. Chem. 273:8048.
65. Sandstrom, P. A., B. Roberts, T. M. Folks, and T. M. Buttke. 1993. HIV gene expression enhances T cell susceptibility to hydrogen peroxide-induced apoptosis. AIDS Res. Hum. Retroviruses 9:1107.
66. Kwon, J., S. Devadas, and M. S. Williams. 2003. T cell receptor-stimulated generation of hydrogen peroxide inhibits MEK-ERK activation and lck serine phosphorylation. Free Radical Biol. Med. 35:406.
67. Reth, M. 2002. Hydrogen peroxide as second messenger in lymphocyte activation. Nat. Immunol. 3:1129.
68. Ameisen, J. C. 1995. From cell activation to cell depletion. The programmed cell death hypothesis of AIDS pathogenesis. Adv. Exp. Med. Biol. 374:139.
69. Lane, H. C., and A. S. Fauci. 1985. Immunologic abnormalities in the acquired immunodeficiency syndrome. Annu. Rev. Immunol. 3:477.
70. Katsikis, P. D., M. E. Garcia-Ojeda, J. F. Torres-Roca, D. R. Greenwald, and L. A. Herzenberg. 1997. HIV type 1 Tat protein enhances activation- but not Fas (CD95)-induced peripheral blood T cell apoptosis in healthy individuals. Int. Immunol. 9:835.
71. Paiki, A. H., and M. M. Lederman. 1996. HIV-1 Tat protein and its inhibitor Ro 24-7429 inhibit lymphocyte proliferation and induce apoptosis in peripheral blood mononuclear cells from healthy donors. Cell Immunol. 169:40.
72. Embretson, J., M. Zupancic, J. L. Ribas, A. Burke, P. Racz, K. Tenner-Racz, and A. T. Haase. 1993. Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature 362:359.
73. Pantaleo, G., C. Graziosi, J. F. Demarest, L. Butini, M. Montroni, C. H. Fox, J. M. Orenstein, D. P. Kotler, and A. S. Fauci. 1993. HIV infeciion is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 362:355.
74. Jacotot, E., L. Ravagnan, M. Loeffler, K. F. Ferri, H. L. Vieira, N. Zamzami, P. Costantini, S. Druillennec, J. Hoebeke, J. P. Briand, et al. 2000. The HIV-1 viral protein R induces apoptosis via a direct effect on the mitochondrial permeability transition pore. J. Exp. Med. 191:33.
75. Casella, C. R., E. L. Rapaport, and T. H. Finkel. 1999. Vpo increases susceptibility of human immunodeficiency virus type 1-infected cells to fas killing. J. Virol. 73:92.
76. + T lymphoid cells to apoptosis via functional upregulation of the CD95/ CD95 ligand pathway. Blood 93:1000.
77. + T cells. Proc. Natl. Acad. Sci. USA 97:1178.
78. Hashimoto, F., N. Oyaizu, V. S. Kalyanaraman, and S. Pahwa. 1997. Modulation of Bcl-2 protein by CD4 cross-linking: a possible mechanism for lymphocyte apoptosis in human immunodeficiency virus infection and for rescue of apoptosis by interleukin-2. Blood 90:745.
79. + T cells. Proc. Natl. Acad. Sci. USA 95:12556.
80. Banda, N. K., J. Bernier, D. K. Kurahara, R. Kurrle, N. Haigwood, R. P. Sekaly, and T. H. Finkel. 1992. Crosslinking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis. J. Exp. Med. 176:1099.
81. Oyaizu, N., T. W. McCloskey, M. Coronesi, N. Chirmule, V. S. Kalyanaraman, and S. Pahwa. 1993. Accelerated apoptosis in peripheral-blood mononuclear cells (PBMCs) from human immunodeficiency virus type-1 infected patients and in CD4 cross-linked PBMCs from normal individuals. Blood 82:3392.
82. Badley, A. D., J. A. McElhinny, P. J. Leibson, D. H. Lynch, M. R. Alderson, and C. V. Paya. 1996. Upregulation of Fas ligand expression by human immunodeficiency virus in human macrophages mediates apoptosis of uninfected T lymphocytes. J. Virol. 70:199.
83. + T cells from human immunodeficiency virus-infected persons. J. Exp. Med. 182:1759.